Shire appoints Olivier Bohuon to its board of directors
Shire has announced the appointment of Olivier Bohuon to the Shire board of directors as a non-executive director. Olivier will also be a member of the Science & Technology Committee of the board. Both appointments will be effective from July 1, 2015.
Olivier has served as chief executive officer of Smith & Nephew plc, a global medical technology company, since 2011. He has extensive international business and leadership experience across a number of pharmaceutical and healthcare companies in Europe, the Middle East and US. He also serves as a Non-executive director of Virbac group.
Susan Kilsby, Shire’s chairman, says: “Olivier Bohuon further enriches the Shire board of directors, bringing direct experience and deep knowledge of pharmaceuticals and healthcare in today’s fast-changing global environment as well as executive and board leadership in dynamic industries such as medical technology. We are especially pleased he will join the Shire Board at a time we are rapidly transforming to a global biotech focused on the unmet medical needs in rare diseases and other specialty conditions.”
Olivier is a member of the Smith & Nephew board of directors, where he also serves on the Nomination & Governance Committee. Prior to Smith & Nephew, Olivier served as the chief executive officer and president of Pierre Fabre Group, and as President of Abbott Pharmaceuticals. He has also held diverse commercial leadership positions for GlaxoSmithKline and its predecessor companies in France. Olivier has an MBA from HEC Paris School of Management and a doctorate in pharmacy from the University of Paris.